Daniel Bradbury
Managing Member at BioBrit
San Diego County, California
Overview
Work Experience
Managing Member
2012 - Current
BioBrit, LLC is a Life Sciences Consulting and Investment Firm. www.biobrit.com
Executive Chairman
2020
Chairman of the Board and Chief Executive Officer
2017 - 2019
www.equilliumbio.com
Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.
Raised $85,000,000.00 from Decheng Capital.
Chairman of the Board
2023
Director
2022
Abilita Therapeutics, Inc. is a biotechnology company.
Executive Chairman
2021
Director
2020
Director
2019
Synedgen develops novel therapies and products to reduce infection and inflammation of dermal, oral, mucosal, and ophthalmic surfaces.
Raised $28,836,397.00 from Congressionally Directed Medical Research Programs.
Director
2019
Director
2018
Chairman Of The Board
2017
Biolinq develops a wearable biosensor platform that is capable of measuring blood level information.
Raised $254,251,237.00 from Niterra Ventures, Taisho Pharmaceutical Holdings, Features Capital, Aphelion Capital, Alpha Wave Ventures, Global Health Investment Corporation, Senvest Management, AXA Investment Managers, Pegasus Tech Ventures and RiverVest.
Education
AMP
1994 - 1994
Bachelor of Pharmacy (B.Pharm.)
1980 - 1983